To examine the effect of TNFAIP8 on drug resistance, TNFAIP8-transfected cells were treated with increasing concentrations of two anti-liver cancer drugs, sorafenib, and regorafenib (Fig. 2d). The gene discussed is TNFAIP8; the disease is liver cancer.